Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in PLoS Med

Retrieve available abstracts of 7 articles:
HTML format



Single Articles


    February 2022
  1. KAMPITSI CE, Mogensen H, Feychting M, Tettamanti G, et al
    The relationship between congenital heart disease and cancer in Swedish children: A population-based cohort study.
    PLoS Med. 2022;19:e1003903.
    PubMed     Abstract available


    October 2021
  2. ODENY B
    Cancer Special Issue: Early detection and minimal residual disease.
    PLoS Med. 2021;18:e1003794.
    PubMed     Abstract available


  3. ABBOSH C, Swanton C
    ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors.
    PLoS Med. 2021;18:e1003771.
    PubMed     Abstract available


    June 2021
  4. TONA LUTETE G, Mombo-Ngoma G, Assi SB, Bigoga JD, et al
    Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.
    PLoS Med. 2021;18:e1003669.
    PubMed     Abstract available


    May 2021
  5. TIE J, Wang Y, Cohen J, Li L, et al
    Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
    PLoS Med. 2021;18:e1003620.
    PubMed     Abstract available


    June 2020
  6. ATABAKI-PASDAR N, Ohlsson M, Vinuela A, Frau F, et al
    Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts.
    PLoS Med. 2020;17:e1003149.
    PubMed     Abstract available


    April 2020
  7. JARVIS H, Craig D, Barker R, Spiers G, et al
    Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    PLoS Med. 2020;17:e1003100.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: